- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
Patent holdings for IPC class A61K 31/437
Total number of patents in this class: 9502
10-year publication summary
687
|
685
|
710
|
762
|
795
|
794
|
746
|
772
|
620
|
173
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Bristol-myers Squibb Company | 5080 |
194 |
F. Hoffmann-La Roche AG | 7958 |
134 |
Takeda Pharmaceutical Company Limited | 2961 |
131 |
Novartis AG | 11238 |
120 |
Incyte Corporation | 918 |
116 |
Genentech, Inc. | 3742 |
113 |
Janssen Pharmaceutica N.V. | 3839 |
108 |
Merck Sharp & Dohme LLC | 3689 |
95 |
Boehringer Ingelheim International GmbH | 4629 |
93 |
Merck Patent GmbH | 5909 |
88 |
Gilead Sciences, Inc. | 1879 |
71 |
Bayer Pharma AG | 1096 |
70 |
Pfizer Inc. | 3322 |
67 |
Abbvie Inc. | 1808 |
64 |
Dana-Farber Cancer Institute, Inc. | 2455 |
64 |
Hoffmann-La Roche Inc. | 3060 |
59 |
Galapagos NV | 304 |
59 |
The Regents of the University of California | 18943 |
58 |
Plexxikon Inc. | 168 |
58 |
AstraZeneca AB | 3042 |
56 |
Other owners | 7684 |